Back to top
more

Chemours (CC)

(Real Time Quote from BATS)

$26.60 USD

26.60
270,290

-0.48 (-1.77%)

Updated Apr 25, 2024 01:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 251)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for CC

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for The Chemours Company falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 1,807 1,102 1,451 1,105 943
Receivables 610 626 720 511 674
Notes Receivable 0 0 0 0 0
Inventories 1,352 1,404 1,099 939 1,079
Other Current Assets 66 82 75 78 81
Total Current Assets 3,835 3,214 3,345 2,633 2,777
Net Property & Equipment 3,216 3,171 3,154 3,474 3,559
Investments & Advances 158 175 169 167 162
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 105 115 108 167 174
Deposits & Other Assets 677 725 547 405 292
Total Assets 8,251 7,640 7,550 7,082 7,258
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 1,159 1,251 1,162 844 923
Current Portion Long-Term Debt 51 25 25 21 134
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 1,058 300 325 577 484
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 218 315 346 0 0
Total Current Liabilities 2,486 1,891 1,858 1,442 1,541
Mortgages 0 0 0 0 0
Deferred Taxes/Income 44 61 49 36 118
Convertible Debt 0 0 0 0 0
Long-Term Debt 3,987 3,590 3,724 4,005 4,026
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 789 793 658 590 633
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 7,512 6,533 6,468 6,267 6,563
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2 2 2 2 2
Capital Surplus 1,033 1,016 944 890 859
Retained Earnings 1,782 2,170 1,746 1,303 1,249
Other Equity -272 -343 -363 -308 -343
Treasury Stock 1,806 1,738 1,247 1,072 1,072
Total Shareholder's Equity 739 1,107 1,082 815 695
Total Liabilities & Shareholder's Equity 8,251 7,640 7,550 7,082 7,258
Total Common Equity 739 1,107 1,082 815 695
Shares Outstanding 148.40 150.90 162.90 164.50 163.50
Book Value Per Share 4.98 7.34 6.64 4.95 4.25

Fiscal Year End for The Chemours Company falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 1,807 1,447 945 816
Receivables NA 610 846 890 837
Notes Receivable NA 0 0 0 0
Inventories NA 1,352 1,314 1,446 1,486
Other Current Assets NA 66 76 93 63
Total Current Assets NA 3,835 3,683 3,374 3,202
Net Property & Equipment NA 3,216 3,119 3,190 3,180
Investments & Advances NA 158 192 189 185
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 105 107 110 112
Deposits & Other Assets NA 677 589 553 707
Total Assets NA 8,251 7,948 7,660 7,624
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 1,159 901 1,009 1,166
Current Portion Long-Term Debt NA 51 23 25 25
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 1,058 1,039 930 300
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 218 232 226 254
Total Current Liabilities NA 2,486 2,195 2,190 1,745
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 44 54 58 60
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 3,987 3,944 3,604 3,599
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 791 802 797
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 7,512 7,191 6,850 6,396
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 2 2 2 2
Capital Surplus NA 1,033 1,030 1,014 1,004
Retained Earnings NA 1,782 1,845 1,864 2,278
Other Equity NA -272 -313 -280 -305
Treasury Stock NA 1,806 1,807 1,790 1,751
Total Shareholder's Equity NA 739 757 810 1,228
Total Liabilities & Shareholder's Equity NA 8,251 7,948 7,660 7,624
Total Common Equity 0 739 757 810 1,228
Shares Outstanding 148.80 148.40 148.40 148.00 149.10
Book Value Per Share 0.00 4.98 5.10 5.47 8.24